Barriers to successful tuberculosis treatment in Tomsk, Russian Federation: non-adherence, default and the acquisition of multidrug resistance.
about
Natural infection of guinea pigs exposed to patients with highly drug-resistant tuberculosisRisk Factors for Acquired Rifamycin and Isoniazid Resistance: A Systematic Review and Meta-AnalysisThe perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central AsiaTuberculosis Treatment Non-Adherence and Lost to Follow Up among TB Patients with or without HIV in Developing Countries: A Systematic ReviewSurgical face masks worn by patients with multidrug-resistant tuberculosis: impact on infectivity of air on a hospital wardInfection Control for Drug-Resistant Tuberculosis: Early Diagnosis and Treatment Is the KeyOutcomes after chemotherapy with WHO category II regimen in a population with high prevalence of drug resistant tuberculosisTreatment default amongst patients with tuberculosis in urban Morocco: predicting and explaining default and post-default sputum smear and drug susceptibility resultsPatient and Provider Reported Reasons for Lost to Follow Up in MDRTB Treatment: A Qualitative Study from a Drug Resistant TB Centre in IndiaThe Role of Adherence and Retreatment in De Novo Emergence of MDR-TBAgents of change: The role of healthcare workers in the prevention of nosocomial and occupational tuberculosis.The association between alcohol use, alcohol use disorders and tuberculosis (TB). A systematic review.Default from tuberculosis treatment in Tashkent, Uzbekistan; who are these defaulters and why do they default?Adherence to anti-tuberculosis treatment among pulmonary tuberculosis patients: a qualitative and quantitative studyRisk factors for treatment default among re-treatment tuberculosis patients in India, 2006.Integrated Management of Physician-delivered Alcohol Care for Tuberculosis Patients: Design and Implementation.Development of extensively drug-resistant tuberculosis during multidrug-resistant tuberculosis treatment.Patient- and provider-level risk factors associated with default from tuberculosis treatment, South Africa, 2002: a case-control study.Factors associated with tuberculosis treatment default in an endemic area of the Brazilian Amazon: a case control-studyTuberculosis and illicit drug use: review and update.Levels of tuberculosis treatment adherence among sputum smear positive pulmonary tuberculosis patients attending care at Zomba Central hospital, southern Malawi, 2007-2008Incidence, time and determinants of tuberculosis treatment default in Yaounde, Cameroon: a retrospective hospital register-based cohort study.A nested case-control study on relapse predictors among tuberculosis patients treated in Yemen's NTCP.Risk factors associated with loss to follow-up among multidrug-resistant tuberculosis patients in Georgia.Multidrug resistance after inappropriate tuberculosis treatment: a meta-analysisTransmission of Extensively Drug-Resistant Tuberculosis in South Africa.Hazardous and harmful alcohol use and associated factors in tuberculosis public primary care patients in South Africa.Outcomes and follow-up of patients treated for multidrug-resistant tuberculosis in Orel, Russia, 2002-2005.Factors Associated with Loss to Follow-up during Treatment for Multidrug-Resistant Tuberculosis, the Philippines, 2012-2014Triplex real-time PCR melting curve analysis for detecting Mycobacterium tuberculosis mutations associated with resistance to second-line drugs in a single reaction.Psychiatric morbidity and other factors affecting treatment adherence in pulmonary tuberculosis patients.Turning off the spigot: reducing drug-resistant tuberculosis transmission in resource-limited settingsRisk factors and timing of default from treatment for non-multidrug-resistant tuberculosis in MoldovaAlcohol use and abuse among patients with multidrug-resistant tuberculosis in Botswana.A systematic review of the effectiveness of hospital- and ambulatory-based management of multidrug-resistant tuberculosis.Study of tuberculosis and AIDS stigma as barriers to tuberculosis treatment adherence using validated stigma scalesMycobacterium tuberculosis mutation rate estimates from different lineages predict substantial differences in the emergence of drug-resistant tuberculosis.Alcohol/Substance misuse and treatment nonadherence: fatal attractionSystemic barriers accessing HIV treatment among people who inject drugs in Russia: a qualitative study.High risk and rapid appearance of multidrug resistance during tuberculosis treatment in Moldova.
P2860
Q24170218-7237CC5E-11CC-451A-9E13-49BBFED181ECQ26781111-B4724C5A-9503-4212-9677-AF6377DE7960Q28077903-E0180113-EF3A-4483-9721-2BA45A54AC4FQ28087010-9B18E51B-1365-46F3-8105-B8FA2A94B916Q28384771-FADE40CC-DC84-412A-9D14-5588F9EEE6FDQ28393098-641E80D3-B937-4D7D-A866-1BBEDD9FB1E9Q28471986-0C7F5B15-14D8-499B-B62F-6B118648C1C5Q28541909-5014D10B-13B7-475F-981D-7860A007B6CEQ28547430-1C60E5E7-350E-4F0B-8D85-47CB91B57887Q28550707-EBB49C2F-BC2D-4609-B50B-B56F23516909Q30235453-212C7F54-1E0E-47F4-BAB6-2C7D3ABE89D4Q30955276-ECFF84E5-A650-468C-8EA3-682D4899DE8CQ33353846-BA4E6E52-3FE7-41AE-BC8B-2E5BFB050821Q33504881-CAB12E83-5D21-4CE8-AF10-0AF241E18A3FQ33527437-1EF0190D-5F40-4B00-872F-C4740637B51EQ33967666-C22C357A-8E3F-4A82-A9C6-99E9EA3E06C1Q34065647-36540A0A-2BBE-42E3-99F0-80B658FCD44CQ34134599-5304260C-574B-4E7D-8B8C-B85D9E3C6937Q34312188-DFACB368-2BDD-4CDD-B2A7-0F4D5BE3634CQ34601143-00C2A6E1-FD1C-4800-8A3D-F8A046B289D8Q34749214-7F8EAC96-61AE-4BA8-8BC4-6084BF28D30CQ35577326-047C329D-7F08-4782-8DFD-72C57C38E148Q35718688-8A71D661-B8C7-49FC-9185-54DB6E4F1EB4Q35990631-A2B0BE62-704F-4274-B084-755B887C4ADBQ36001543-8C12F0B8-9C05-4F62-9958-674B7C0DD88EQ36252929-08A827E2-5AA5-44FC-9BFA-A7CBBE904612Q36404314-FF7CC706-33A0-4423-A6E5-1263AE00494EQ36420040-BCB3E1CE-5D1F-4E33-93FF-1E55A053CF64Q36617035-C9B31B81-E761-46A6-91D4-2C2066C76A61Q36762984-8B0B9A70-8AFD-4D29-BEC6-91A14DF07272Q36830922-C892AC62-9D20-44A1-873A-1E6C5F12A614Q37006543-C98360DE-5D3D-40CF-8C51-D0284C2A6995Q37010202-89A4CEB6-43A4-42B4-91E8-DB8088BB1079Q37061235-21F63910-DDDD-481F-B918-CA00E47957DBQ37089599-A69B7335-0AE8-4CA3-86A8-4E5143A0AAB3Q37122265-F7E305EB-2DCA-42BD-BD86-70517EEF6DE9Q37184072-84CECD45-F46C-4E04-8B96-02A31670DA52Q37203897-D8BD9E1B-C44A-4359-8A04-E3D4B98BC781Q37224404-9ED9DC71-EBAF-47F3-8844-FD10D59DE278Q37733149-672B30FE-7B6D-4173-8CAD-E15F29D65C4B
P2860
Barriers to successful tuberculosis treatment in Tomsk, Russian Federation: non-adherence, default and the acquisition of multidrug resistance.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Barriers to successful tubercu ...... ition of multidrug resistance.
@en
Barriers to successful tubercu ...... ition of multidrug resistance.
@nl
type
label
Barriers to successful tubercu ...... ition of multidrug resistance.
@en
Barriers to successful tubercu ...... ition of multidrug resistance.
@nl
prefLabel
Barriers to successful tubercu ...... ition of multidrug resistance.
@en
Barriers to successful tubercu ...... ition of multidrug resistance.
@nl
P2093
P2860
P356
P1476
Barriers to successful tubercu ...... ition of multidrug resistance.
@en
P2093
Berezina VI
Gelmanova IY
Golubchikova VT
Keshavjee S
Strelis AK
P2860
P304
P356
10.2471/BLT.06.038331
P407
P577
2007-09-01T00:00:00Z